PT941081E - Nova utilizacao de creatina - Google Patents

Nova utilizacao de creatina

Info

Publication number
PT941081E
PT941081E PT97951157T PT97951157T PT941081E PT 941081 E PT941081 E PT 941081E PT 97951157 T PT97951157 T PT 97951157T PT 97951157 T PT97951157 T PT 97951157T PT 941081 E PT941081 E PT 941081E
Authority
PT
Portugal
Prior art keywords
creatine
new use
new
Prior art date
Application number
PT97951157T
Other languages
English (en)
Inventor
Marco Anelli
Ettore Strumia
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT941081(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of PT941081E publication Critical patent/PT941081E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT97951157T 1996-11-19 1997-11-10 Nova utilizacao de creatina PT941081E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria

Publications (1)

Publication Number Publication Date
PT941081E true PT941081E (pt) 2003-04-30

Family

ID=11375243

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97951157T PT941081E (pt) 1996-11-19 1997-11-10 Nova utilizacao de creatina

Country Status (13)

Country Link
US (1) US6242490B1 (pt)
EP (1) EP0941081B1 (pt)
CN (2) CN1237904A (pt)
AR (1) AR009425A1 (pt)
AT (1) ATE230983T1 (pt)
BR (1) BR9713514A (pt)
DE (1) DE69718506T2 (pt)
DK (1) DK0941081T3 (pt)
ES (1) ES2191206T3 (pt)
IT (1) IT1298420B1 (pt)
PT (1) PT941081E (pt)
RU (1) RU2202345C2 (pt)
WO (1) WO1998022099A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US20030212136A1 (en) 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US9833427B2 (en) 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060025475A1 (en) * 2004-07-29 2006-02-02 Stanley Antosh Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) * 2004-09-04 2006-03-09 Mr. Stanley Antosh Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (pt) * 1973-06-27 1977-07-01 Biotherax Lab
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
WO1998000148A1 (de) * 1996-06-28 1998-01-08 Ipr-Institute For Pharmaceutical Research Ag Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink

Also Published As

Publication number Publication date
US6242490B1 (en) 2001-06-05
WO1998022099A2 (en) 1998-05-28
ITMI962408A1 (it) 1998-05-19
DE69718506D1 (de) 2003-02-20
EP0941081B1 (en) 2003-01-15
DK0941081T3 (da) 2003-04-22
IT1298420B1 (it) 2000-01-05
AR009425A1 (es) 2000-04-12
CN1623534A (zh) 2005-06-08
WO1998022099A3 (en) 1998-07-09
ITMI962408A0 (it) 1996-11-19
ES2191206T3 (es) 2003-09-01
EP0941081A2 (en) 1999-09-15
DE69718506T2 (de) 2003-07-31
BR9713514A (pt) 2000-02-29
ATE230983T1 (de) 2003-02-15
CN1237904A (zh) 1999-12-08
RU2202345C2 (ru) 2003-04-20

Similar Documents

Publication Publication Date Title
PT946547E (pt) Nova forma de composto
NO971727L (no) Belegningsblanding
DE69513300T2 (de) Bestimmungsverfahren
ID26488A (id) Pelapis elastis
DE69720111T2 (de) Vorläufer von Duftstoffen
PT927183E (pt) Inibidores espirociclicos de metaloproteases
IS4898A (is) Sáraumbúðir
PT941081E (pt) Nova utilizacao de creatina
MA23794A1 (fr) Utilisation de phenylcyclohexylcarboxamides
DE59705708D1 (de) Lagebestimmung von peripherieeinheiten
BR9706702A (pt) Purificação de 1,1,1,3,3-pentafluorpropano
DE69705349T2 (de) Elektroplattierungsbad
NO985458D0 (no) Vµskegjennomslippbart belegg
BR9711681A (pt) Novos m-todos
ID17383A (id) Penggunaan terbaru turunan turunan sistina
FR2744447B1 (fr) Utilisation de derives de tetrahydroisoquinoleine
KR980000948U (ko) 블록 놀이 기구
FI960151A (fi) Instrumentti
DE69713849D1 (de) Elektroplattierungsverfahren
BR9708484A (pt) Aplicação de arilimidazóis substituídos
KR980003137U (ko) 퇴수를 재공급 사용토록 한 개량부동전
ID17328A (id) Pemurnian epsilon-kaprolaktam
DK0942053T3 (da) Coatingmateriale
FI971253A (fi) Lyoluminesenssin käyttö analyyttisiin tarkoituksiin
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia